Gene: PARP2
Official Full Name: poly(ADP-ribose) polymerase 2provided by HGNC
Gene Summary: This gene encodes poly(ADP-ribosyl)transferase-like 2 protein, which contains a catalytic domain and is capable of catalyzing a poly(ADP-ribosyl)ation reaction. This protein has a catalytic domain which is homologous to that of poly (ADP-ribosyl) transferase, but lacks an N-terminal DNA binding domain which activates the C-terminal catalytic domain of poly (ADP-ribosyl) transferase. The basic residues within the N-terminal region of this protein may bear potential DNA-binding properties, and may be involved in the nuclear and/or nucleolar targeting of the protein. Two alternatively spliced transcript variants encoding distinct isoforms have been found. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00627 | PARP2 Knockout cell line(A549) | Human | PARP2 | 1:3~1:4 | Negative | Online Inquiry |
KO02015 | PARP2 Knockout cell line (HeLa) | Human | PARP2 | 1:3~1:6 | Negative | Online Inquiry |
KO02016 | PARP2 Knockout cell line (HCT 116) | Human | PARP2 | 1:2~1:4 | Negative | Online Inquiry |
KO02017 | PARP2 Knockout cell line (HEK293) | Human | PARP2 | 1:3~1:6 | Negative | Online Inquiry |
PARP2 Gene Knockout Cell Lines are specialized cellular models in which the PARP2 gene has been intentionally disrupted, rendering them invaluable tools for investigating the role of poly(ADP-ribose) polymerase 2. PARP2 plays a critical role in the DNA damage repair process, contributing to cellular responses to genotoxic stress. By elucidating these mechanisms, PARP2 knockout cell lines provide a unique platform for studying the effects of PARP2 deficiency on genomic stability, cell cycle regulation, and apoptosis.
These cell lines function by exhibiting altered cellular behavior compared to wild-type counterparts, largely due to the lack of PARP2-mediated signaling in response to DNA damage. This disruption enables researchers to explore the functional consequences of PARP2 interference on pathways such as homologous recombination and base excision repair, thus advancing our understanding of cancer biology and therapeutic resistance.
The scientific importance of these cell lines extends to clinical applications, particularly in the development of targeted therapies for cancers that exhibit PARP pathway dysregulation. Understanding the specific role of PARP2 in tumor progression or treatment response can facilitate the design of more effective combination therapies, ultimately improving patient outcomes.
What sets our PARP2 Gene Knockout Cell Lines apart from alternatives is their high reliability, consistent performance, and robust genetic validation, ensuring that researchers and clinicians obtain reproducible results. Additionally, we provide extensive support and resources, including detailed characterization data and protocols for optimal utilization of the cell lines.
Research professionals and clinicians will find significant value in using these cell lines to explore new therapeutic avenues, get insights into DNA repair mechanisms, and inform clinical strategies for a range of malignancies. Our company prides itself on expertise in the production of advanced biological research tools, fostering innovation and scientific discovery in the biomedical field.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.